Diabetes mellitus type 1 / 2

What Is Diabetes Mellitus?

Diabetes mellitus is a chronic condition in which the body cannot properly regulate blood glucose levels, either because the pancreas fails to produce enough insulin, the hormone responsible for allowing cells to absorb glucose from the bloodstream, or because the body’s cells no longer respond effectively to the insulin that is produced.¹

Type one and type two diabetes represent the two most common forms of the condition, and while both ultimately result in elevated blood sugar, they arise through fundamentally different mechanisms. Type one diabetes is an autoimmune condition in which the immune system destroys the pancreas’s insulin producing cells, while type two diabetes develops primarily through a combination of insulin resistance and progressively declining insulin production.¹

This distinction matters enormously for treatment, since type one diabetes always requires insulin replacement from the time of diagnosis, while type two diabetes can often be managed initially through lifestyle changes and oral medications before insulin becomes necessary, if it ever does.²

In type two diabetes, insulin resistance coupled with reduced insulin output appears to be the major cause of hyperglycemia, distinguishing its underlying mechanism from type one diabetes.
National Center for Biotechnology Information

Symptoms

Both types of diabetes can produce a similar core set of symptoms, including increased thirst, frequent urination, unexplained weight loss, increased hunger, fatigue, and slow healing sores or wounds, though the pace at which symptoms develop often differs meaningfully between the two types.¹

Type one diabetes symptoms often develop relatively quickly, sometimes over days to weeks, reflecting the rapid loss of insulin production as the immune system destroys pancreatic cells, and severe cases can present suddenly with a dangerous complication called diabetic ketoacidosis.¹

Type two diabetes symptoms, by contrast, frequently develop gradually over months to years, sometimes so slowly that many people remain unaware they have the condition until it is identified during routine blood testing or after complications have already begun to develop.¹

Causes

Type one diabetes results from an autoimmune attack in which the immune system mistakenly targets and destroys the insulin producing beta cells within the pancreas, a process believed to result from a combination of genetic susceptibility and environmental triggers that are not yet fully understood.¹

Type two diabetes develops through a different, more gradual process, in which the body’s cells become progressively less responsive to insulin, a state called insulin resistance, while the pancreas simultaneously struggles to produce enough additional insulin to compensate for this reduced sensitivity.¹

Obesity and physical inactivity represent major contributing factors to type two diabetes development, working alongside genetic predisposition to determine individual risk, while type one diabetes shows a less direct connection to lifestyle factors and instead reflects a primarily immune mediated disease process.¹

Risk Factors

A family history of diabetes in a first degree relative meaningfully raises risk for both types, though the specific genetic factors involved differ considerably between type one and type two diabetes.³

For type two diabetes specifically, age over forty five, obesity, physical inactivity, a history of gestational diabetes, and polycystic ovary syndrome all represent well established risk factors, reflecting the condition’s strong connection to metabolic and lifestyle related factors.³

Type one diabetes risk factors center more heavily around genetic susceptibility and family history of autoimmune conditions, and while it can occur at any age, it is most frequently diagnosed in children and young adults, distinguishing its typical age of onset from type two diabetes.¹

Complications

Diabetic peripheral neuropathy represents the most common chronic complication of diabetes, affecting a substantial proportion of patients over time and serving as a leading cause of diabetic foot problems and, in severe cases, lower limb amputation.³

Both types of diabetes meaningfully increase the risk of cardiovascular disease, kidney disease, and vision threatening eye complications, though research has found some differences in complication patterns between the two types, including notably different rates of neuropathy.²

Controlling both elevated insulin levels and elevated blood glucose is essential to avoiding the serious macrovascular and microvascular complications associated with diabetes, underscoring why comprehensive, consistent management matters so much regardless of which type of diabetes a person has.³

Treatment

Type one diabetes requires lifelong insulin therapy from the time of diagnosis, since the body can no longer produce this essential hormone on its own, typically delivered through multiple daily injections or a continuous insulin pump.¹

For type two diabetes, metformin is generally recommended as first line medication treatment by major health organizations worldwide, working to reduce glucose production by the liver and improve the body’s sensitivity to insulin, and it has additionally been associated with reduced risk of certain diabetes related complications, including specific forms of eye disease.⁴

As type two diabetes progresses, additional medications, and eventually insulin therapy for some patients, may become necessary to maintain adequate blood sugar control, with treatment intensity generally increasing over time as the condition’s underlying insulin producing capacity continues to decline.²

Prevention

Type one diabetes currently cannot be prevented, since it results from an autoimmune process with no established, reliable prevention strategy available at this time.¹

Type two diabetes, by contrast, can often be delayed or prevented through lifestyle interventions, with research showing that metformin combined with lifestyle changes can meaningfully reduce diabetes incidence among high risk individuals, including those with prediabetes.⁵

Regular physical activity, maintaining a healthy body weight, and consistent, balanced nutrition all meaningfully reduce type two diabetes risk, making lifestyle modification a genuinely important and effective prevention strategy for this specific form of the condition.²

Why Visual Communication Matters for Diabetes Mellitus

Explaining the fundamental difference between an autoimmune attack on the pancreas and gradually developing insulin resistance requires visuals that clearly distinguish these two related but biologically distinct conditions, both of which are frequently and understandably confused by patients and the general public alike.¹

Pharmaceutical companies, endocrinology practices, and patient education organizations rely on clear illustration and animation to explain diabetes biology and help patients understand their specific type, treatment plan, and long term management strategy.

• Illustrating the autoimmune process underlying type one diabetes
• Animating insulin resistance and progressive beta cell decline in type two diabetes
• Explaining the mechanism of action for insulin and oral diabetes medications
• Visualizing how uncontrolled blood sugar contributes to long term complications
• Supporting patient education on blood sugar monitoring and daily management
• Creating training materials for endocrinology and primary care clinicians

How Biotic Artlab Supports Diabetes Mellitus Communication

We work with pharmaceutical companies, endocrinology practices, and patient advocacy organizations to create accurate, engaging visuals that make diabetes biology and management easier to understand for patients and clinicians alike.

• Custom 3D animations of pancreatic beta cell function and insulin signaling
• Detailed illustrations comparing type one and type two diabetes mechanisms
• Mechanism of action animations for insulin and oral diabetes medications
• Patient facing educational materials on complication prevention and daily management
• Clinical training content for endocrinology and primary care teams
• Conference presentations and marketing visuals for diabetes care audiences

Frequently Asked Questions

What is the main difference between type one and type two diabetes?

Type one diabetes results from autoimmune destruction of insulin producing cells and always requires insulin treatment, while type two diabetes involves insulin resistance and can often initially be managed with lifestyle changes and oral medication.¹

Can type two diabetes be reversed?

Some people achieve significant improvement or remission through substantial weight loss and lifestyle changes, particularly early in the disease course, though this varies considerably between individuals and does not apply to type one diabetes.²

Is diabetes always inherited?

Family history raises risk for both types, but neither type is guaranteed by genetics alone. Environmental and lifestyle factors also play significant roles, particularly for type two diabetes.³

Why is metformin the first choice for type two diabetes?

Metformin effectively reduces blood sugar by decreasing liver glucose production and improving insulin sensitivity, and it carries a favorable safety profile along with evidence of benefit for certain diabetes related complications.⁴

Can type two diabetes be prevented?

Yes, for many people. Regular physical activity, healthy weight management, and balanced nutrition, sometimes combined with medication such as metformin, can meaningfully reduce the risk of developing type two diabetes, particularly in high risk individuals.⁵

What complications are people with diabetes at risk for?

Both types carry increased risk of nerve damage, kidney disease, cardiovascular disease, and eye complications, with consistent blood sugar control representing the most important strategy for reducing these long term risks.³

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to diabetes mellitus or metabolic health, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Type 1 and Type 2 Diabetes Mellitus, Commonalities, Differences and the Importance of Exercise and Nutrition.
2. National Center for Biotechnology Information. Pathophysiology of Type 2 Diabetes Mellitus.
3. National Center for Biotechnology Information. Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes, A Systematic Review.
4. National Center for Biotechnology Information. Metformin Treatment Is Associated With a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
5. National Center for Biotechnology Information. Metformin’s Overall Effectiveness and Combined Action With Lifestyle Interventions in Preventing Type 2 Diabetes Mellitus in High Risk Metformin Naive Patients.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.